Conference
The timing of dosing of zoledronic acid 5mg after recent hip fracture affects antifracture efficacy and reduction of mortality: Results from horizon-recurrent fracture trial
Authors
Eriksen EF; Lyles KW; Colon-Emeric CS; Pieper CF; Magaziner JS; Adachi JD; Hyldstrup L; Recknor C; Nordsletten L; Lavecchia C
Volume
82
Pagination
pp. S41-S41
Publisher
SPRINGER
Publication Date
January 1, 2008
Conference proceedings
CALCIFIED TISSUE INTERNATIONAL
ISSN
0171-967X